Entera Bio Ltd.
ENTXWDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EBP05 | Phase 2 | Osteoporosis | - | - |
Frequently asked questions
What is in Entera Bio Ltd.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Entera Bio Ltd.'s (ENTXW) pipeline across Phase 2. Its lead program is EBP05 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Entera Bio Ltd.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Entera Bio Ltd. (ENTXW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ENTXW biotech catalysts?→
Add ENTXW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Entera Bio Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.